ArticleOrphanet journal of rare diseases2012

Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

Wills Hughes-Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.